Editor's Note Pfizer alerted the Food and Drug Administration (FDA) on June 12 that its supply of two forms of injectable penicillin—Bicillin L-A and Bicillin C-R—may run out by the end of this month, the June 13 The Hill reports. Pfizer cited a combination of factors for the shortage, including…

Read More

Editor's Note The Society for Healthcare Epidemiology of America (SHEA) has updated the Strategies to Prevent Surgical Site Infection in Acute Care Hospitals, which was published in 2014. The update highlights practical recommendations designed to assist acute-care hospitals in implementing and prioritizing their surgical site infection (SSI) prevention efforts. Among…

Read More

Editor's Note This update to the 2014 "Strategies to Prevent Surgical Site Infections in Acute Care Hospitals" recommends that antibiotics be discontinued after a patient’s incision has been closed in the OR, even if drains are present. The expert panel members writing the update add that continuing antibiotics after closure…

Read More

Editor's Note The Joint Commission on June 22 announced a new “R3 Report—Issue 35: New and Revised Requirements for Antibiotic Stewardship,” which details the rationale and references behind new and revised requirements to optimize the use of antibiotics, effective January 1, 2023. The requirements include 12 new and revised elements…

Read More

Editor's Note This study by researchers at the Pennsylvania State University College of Medicine, Hershey, finds that patients who had a penicillin allergy carried a higher risk for negative outcomes with COVID-19 than those without the allergy. This analysis included 13,183 adults with COVID-19 and a penicillin allergy and 13,183…

Read More

Editor's Note In this case study, craniofacial surgeons from Brazil describe their experience with a 28-year-old COVID-19-positive man who developed orbital cellulitis, requiring surgical intervention. A few weeks before, the man had a mild illness with fatigue and loss of smell and taste. He didn’t seek medical care until he…

Read More

Editor's Note This observational study by researchers at Saint Barnabas Medical Center, Livingston, New Jersey, and the Smith Center for Infectious Diseases & Urban Health, East Orange, New Jersey, finds that the use of weight-adjusted hydroxychloroquine (HCQ) and azithromycin (AZM) improved the odds of survival of ventilated COVID-19 patients by…

Read More

Editor's Note In this study, researchers from Henry Ford Health System in Michigan found that hydroxychloroquine alone decreased the mortality hazard ratio of COVID-19 by 66%, and hydroxychloroquine with azithromycin decreased the ratio by 71%, compared to neither treatment. The vast majority of the 2,541 COVID-19 patients included in the…

Read More

Hospitals have long dominated the realms of infection control and antibiotic overuse. Ambulatory surgery centers (ASCs), which typically release patients the same day of a procedure, use antibiotics less frequently than other facilities, and most do not have an antimicrobial stewardship program. However, some ASC leaders and organizations are encouraging…

Read More

Editor's Note More than 2.8 million antibiotic-resistant infections occur in the US each year, resulting in more than 35,000 deaths, according to a new “Antibiotic Resistance Threats in the United States 2019” report from the Centers for Disease Control & Prevention (CDC). The CDC also notes that 223,900 cases of…

Read More